Search results
Pediatric thalassemia: How does thalassemia affect children?
Medical News Today· 4 days agoThalassemia is an inherited disease that affects the blood. Children with severe thalassemia will...
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
InvestorPlace· 2 hours agoCRISPR Therapeutics (NASDAQ:CRSP) is a pioneering gene-editing company revolutionizing the treatment...
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 8 hours agoAgios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The...
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong...
Insider Monkey via Yahoo Finance· 3 hours agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 5 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoThe newer assets in its portfolio are growing in prominence. These include Reblozyl, a treatment for anemia in patients with beta-thalassemia first...
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Motley Fool via Yahoo Finance· 3 days agoMeanwhile, the commercial launch of Casgevy, as a one-time functional cure for sickle cell disease...
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 5 days agoWe recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoVertex and partner Crispr Therapeutics gained Food and Drug Administration approval for a...
In drug-pricing debate, Mass. gene-therapy drugmakers make their case - Boston Business Journal
The Business Journals· 3 days agoWhen a new gene therapy to treat a deadly rare disease called metachromatic leukodystrophy was approved earlier this year, the first thing on Maria Kefalas’ mind wasn’t the price. Kefalas' daughter ...